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104High-resolution magnetic resonance imaging
of carotid atherosclerosis identiﬁes vulnerable
carotid plaques
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Objective: Carotid magnetic resonance imaging (MRI) may be a useful tool in characterizing carotid plaque vulnerability,
but large studies are still lacking. The purpose of this study was to assess carotid MRI features of vulnerable plaque in
a large study and the changes in carotid plaque morphology with respect to time since the neurological event.
Methods: We included 161 patients with carotid plaque more than 3 mm thick. All patients underwent carotid MRI to
obtain 3-T high-resolution magnetic resonance sequences. Large lipid core, intraplaque hemorrhage (IPH), ﬁbrous cap
rupture (FCR), and gadolinium enhancement (GE) were assessed and classiﬁed as present or absent. Prevalences of these
features were then compared between symptomatic and asymptomatic patients and time since stroke.
Results: Seven patients were excluded because of poor image quality. Of the remaining 154 patients, 52 were symptomatic
and 102 were asymptomatic. The prevalences of IPH (39 vs 16%; P[ .002), FCR (30 vs 9%; P[ .001), and GE (75 vs
55%; P [ .015) were signiﬁcantly higher in symptomatic than asymptomatic patients. After multivariate analysis, the
prevalences of IPH (odds ratio, 2.6; P [ .023) and FCR (odds ratio, 2.8; P [ .038) were still signiﬁcantly higher. The
prevalence of IPH was signiﬁcantly higher in symptomatic patients with plaque regardless of the time since the neuro-
logical event. For FCR, the difference between symptomatic and asymptomatic patients was signiﬁcant only during the
ﬁrst 15 days after the neurological event.
Conclusions: Carotid MRI can identify plaque features that are associated with symptomatic presentation and may be
indicative of plaque vulnerability. These features may ultimately be used in the management of extracranial carotid
stenosis. (J Vasc Surg 2013;57:1046-51.)The beneﬁt of carotid endarterectomy or carotid stent-
ing for asymptomatic extracranial carotid stenosis is increas-
ingly being questioned. The average expected annual
ipsilateral stroke rate among hospital-referred patients with
asymptomatic severe carotid stenosis receiving current
medical intervention alone is now around 1%.1,2 Therefore,
stratiﬁcation of patients at “high risk for stroke” is necessary
to improve patient selection for interventional therapies, and
carotid plaque characterization may help achieve this.
Vulnerable or prone-to-rupture carotid plaque has
been deﬁned by extension with coronary artery disease
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6symptomatic patients with carotid plaque, Redgrave et al
reported high prevalences of ﬁbrous cap rupture, large lipid
core, dense macrophage inﬁltrate, and, to a lesser extent,
intraplaque hemorrhage.3 At the same time, accurate in vivo
morphological and functional characterization of the carotid
atheroma has greatly improved, especially since the develop-
ment of high-resolution magnetic resonance imaging (HR-
MRI). Histological correlation studies have demonstrated
the ability of in vivo HR-MRI to detect characteristics of
vulnerable plaque with a high degree of sensitivity and speci-
ﬁcity.4-7 Some studies have already demonstrated that these
features are signiﬁcantly more frequent in symptomatic
patients.8-10 However, most of these studies have been
performed on small numbers of patients. Inﬂammation,
a well-known factor in plaque destabilization, can also be
assessed by HR-MRI as gadolinium enhancement in the
plaque, but very few studies report this feature.11-13
Plaque vulnerability is deﬁned by the high risk of occur-
rence of a neurological event. It is well known that there is
a high risk of stroke recurrence in the ﬁrst 15 days after
a stroke. Therefore, we can assume that plaque is highly
unstable during this period. Accordingly, the present
study investigated the ability of 3-T HR-MRI to determine
features of plaque vulnerability such as large lipid-rich
necrotic core, ﬁbrous cap rupture, intraplaque hemorrhage,
and gadolinium enhancement in carotid plaques in a large
number of symptomatic and asymptomatic patients and
the distribution of these features with time since the neuro-
logical event.
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Study population. The institutional review board
approved the consent form and study protocols. Participants
were identiﬁed among inpatients; outpatients were eligible
for the study if they had carotid plaque thicker than 3 mm
detected by ultrasonography (as it is known that patients
with thick carotid plaque may have a high risk of stroke
even if they do not have severe stenosis) and had no
contraindications to MRI (heart pacemaker, metallic
implant, severe claustrophobia) or intravenous injection of
gadolinium (pregnancy, allergy, glomerular ﬁltration
rate <30 mL/min). A neurologist or a vascular surgeon
experienced in carotid pathology recorded clinical data,
including history of cardiovascular disease, risk factors for
atherosclerosis, medical treatment, neurological event
(stroke, transient ischemic attack, or amaurosis), and time
between neurological event and HR-MRI. Stroke etiology
was determined with a workup based on an imaging package
including one or more of the following examinations as
requested for normal patient care: duplex ultrasound
imaging, magnetic resonance angiography or computed
tomography angiography of the neck and brain vessels, and
transthoracic or transesophageal echocardiography. Patients
with a recent stroke related to a cardiac source, including
atrial ﬁbrillation, intracardiac thrombus, and patent foramen
ovale, were excluded from this study. Biological data
including inﬂammation markers (ultrasensitive C-reactive
protein [usCRP], ﬁbrinogen) were recorded. In addition to
plaque thickness measurement, carotid ultrasonography was
used to assess the degree of stenosis according to the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET) criteria. This population was divided into two
groups: asymptomatic without any neurological events
during the past 6 months, and symptomatic with an ipsi-
lateral carotid-related neurological event during the past 6
months. Symptomatic patients were subdivided into two
subgroups on the basis of time between the neurological
event and HR-MRI (acutely symptomatic patients, <15
days; recently symptomatic patients, 15-180 days).
MRI protocol. Imaging was performed using a 3-T
HR-MRI system (Achieva scanner; Philips Healthcare,
Best, The Netherlands) with a dual-surface coil (Sense Flex
S; Philips Healthcare) positioned on top of the mandibular
angles. This coil was combined with a head holder to
stabilize position and prevent head rotation. A standardized
magnetic resonance protocol was used. After a survey to
determine the position of the carotid bifurcation of interest,
time-of-ﬂight (TOF)-, T1-, and proton density (PD)-
weighted sequences were acquired on the plaque center and
perpendicular to the main carotid axis. Before and after
injection of gadolinium-based contrast agent (Dotarem,
Guerbet, France), a three-dimensional TOF multiple
overlapping thin-slab acquisition magnetic resonance
angiography (MRA) sequence was obtained followed 5
minutes later by a T1-weighted sequence. Total acquisition
time was approximately 45 minutes. Fat suppression was
used for all sequences, and all examinations were performedwith an 18-cm ﬁeld of view. In cases of ultrasound detection
of bilateral plaque >3 mm thick, the largest plaque was
considered of interest if the patient was asymptomatic or the
symptomatic side (regardless of thickness) if the patient was
symptomatic.
Image review. Prior to quantitative analysis, all images
were reviewed to assess image quality. Images with scores
lower than 2 on a 5-point scale (0 ¼ not assessable, 1 ¼
poor, 2 ¼ moderate, 3 ¼ good, 4 ¼ excellent) depending
on the signal-to-noise ratio were excluded from the anal-
ysis. Two experienced observers (L.B., A.M.) blinded to
the clinical history analyzed the magnetic resonance images
and reached a consensus. The observers identiﬁed the lipid-
rich necrotic core (LC) and ﬁbrous cap (FC) based on the
signal intensity for each sequence. Fibrous cap rupture
(FCR), intraplaque hemorrhage (IPH), and gadolinium
enhancement (GE) in the carotid plaque were also assessed
according to previously published criteria (Appendix,
online only). IPH, FCR, large LC ($50%), and GE were
classiﬁed as present or absent.
Statistical analysis. Statistical analysis was performed
with SPSS Version 15.0 (SPSS, Chicago, Ill). Continuous
variables were expressed as means and standard deviations
or ranges. Categorical variables were expressed as frequen-
cies and percentages. Univariate analysis was performed
using a c2 test for categorical variables and a t-test for
continuous variables.
Multivariate analysis was performed using binary
logistic regression models with plaque causing symptoms
in patients as the dependent variable and plaque features
(IPH, FCR, large LC, and GE) as independent variables.
Variables with P < .10 in univariate analysis were entered
into the models. P < .05 were considered statistically
signiﬁcant.
RESULTS
We included 161 patients seen from January 2010 to
November 2011 with carotid plaque thicker than 3 mm
thick. All patients underwent HR-MRI. Seven (4.3%)
patients were excluded because of poor image quality
related to motion artifact (ﬁve cases), metallic dental
implant (one case), and incomplete scan caused by claus-
trophobia (one case). Among the 154 remaining patients,
52 (33%) were symptomatic: 41 strokes, seven transient
ischemic attacks (TIAs), and four cases of amaurosis.
Origin of carotid plaque was de novo atherosclerostic
disease. There was no restenosis or radiation-induced
carotid plaque. Mean delay between symptoms and HR-
MRI was 35.8 6 41.3 days (range, 1-177). Twenty-two
(14%) patients underwent HR-MRI within 15 days
(acutely symptomatic patients) and 30 (19%), between 15
and 180 days (recently symptomatic patients).
Demographic characteristics, medications used, biolog-
ical results, plaque thickness, and NASCET degree of
stenosis are summarized in Table I. Symptomatic and
asymptomatic patients did not signiﬁcantly differ with
respect to demographics or medications used. Diabetes
Table I. Characteristics of the population
Characteristic Symptomatic (n ¼ 5) Asymptomatic (n ¼ 102) P
Age 70 (12, 35-87)a 70 (9, 41-91)a .726
Male gender 73% 71% .746
Active smokers 31% 21% .162
Hypertension 71% 79% .252
Diabetes 21% 36% .055
Dyslipidemia 56% 61% .549
Mean body mass index 25.4 (4.1, 19.1-35.9)a 26.3 (4.1, 19.0-36.2)a .240
Coronary artery disease 17% 29% .102
Statin 75% 81% .357
Aspirin 83% 87% .444
Oral anticoagulant therapy 2% 8% .139
Ultrasensitive C-reactive protein, mg/L 12.4 (41, 0.4-287)a 5.1 (6, 0.2-35.7)a .063
Fibrinogen, g/L 4.0 (1, 2.0-9.0)a 3.9 (1, 2.4-6.8)a .709
Mean plaque thicknes, mm 5.0 (1.4, 3.0-8.3)a 4.9 (1.2, 3.0-7.5)a .293
NASCET degree of stenosis 65% (20, 0-95)a 70% (20, 0-95)a .183
NASCET, North American Symptomatic Carotid Endarterectomy Trial.
aMean (standard deviation, range).
Table II. Carotid plaque features and their distribution among symptomatic and asymptomatic patients
All patients
(n ¼ 154)
Symptomatic patients
(n ¼ 52)
Asymptomatic patients
(n ¼ 102)
Univariate
analysis
P
Multivariate analysis
OR CI P
Intraplaque hemorrhage 36% (23.4) 2% (38.5%) 16% (15.7) .002 2.6 1.1-5.8 .023
Fibrous cap rupture 24% (15.6%) 15% (28.8%) 9% (8.8) .001 2.8 1.1-7.4 .038
Gadolinium enhancement 95% (61.7%) 39% (75.0%) 56% (54.9) .015 1.9 0.9-4.2 .098
Large lipid core 44% (28.6%) 20% (38.5%) 24% (23.5) .052 1.5 0.7-3.3 .333
CI, Conﬁdence interval; OR, odds ratio.
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tomatic patients, and usCRP levels were higher (but not
signiﬁcantly) in symptomatic patients. Mean plaque thick-
ness and mean NASCET degree of stenosis were 4.9 6
1.3 mm (3.0-8.3) and 67 6 20% (0-95%), respectively,
with no difference between symptomatic and asymptomatic
patients. Two (1.3%) patients had no stenosis according
to NASCET criteria, and 22 (14.3%) patients had mild
stenosis (<50%).
Carotid plaque features and their distribution between
symptomatic and asymptomatic patients are summarized in
Table II. Prevalences of IPH, FCR, and GE were signiﬁ-
cantly higher in symptomatic than asymptomatic patients
after univariate analysis. Large LC was also more frequent
in symptomatic patients but without statistical signiﬁcance.
After multivariate analysis, IPH and FCR were still signiﬁ-
cantly higher in symptomatic than in asymptomatic
patients. Carotid plaque features were similarly distributed
in patients with mild (<50%), moderate (50%-70%), and
severe (>70%) stenosis, except for IPH, which was higher
(but not signiﬁcantly) in plaque with severe stenosis
(Table III). We did not observe any difference in terms
of patient characteristics or plaque features during the
study period (results provided in the Supplementary
Table, online only).
After analysis of carotid plaque composition with
respect to time since stroke (Fig), we observed that IPHis signiﬁcantly more frequent in symptomatic patients
than in asymptomatic patients regardless of the time since
stroke (P ¼ .007, acutely symptomatic patients; P ¼
.012, recently symptomatic patients). FCR is signiﬁcantly
more frequent in acutely symptomatic patients than in
asymptomatic patients, whereas its frequency does not
differ between recently symptomatic and asymptomatic
patients. There were no signiﬁcant differences between
subgroups in large LC (P ¼ .212 for acute asymptomatic;
P ¼ .075 for recently symptomatic vs asymptomatic
patients) or GE (P ¼ .053 for acutely symptomatic
patients; P ¼ .071 for recently symptomatic vs asymptom-
atic patients).
Ninety-one (59%) patients underwent carotid endarter-
ectomy (Supplementary Fig, online only). Correlation with
histology was performed for 79 patients. The sensitivity
and speciﬁcity of HR-MRI in the detection of IPH,
FCR, and large LC were respectively 71% and 97%, 70%
and 82%, and 68% and 78%. The prevalences of neovessels,
macrophages, and loose ﬁbrosis in the area of GE were
97%, 87%, and 80%.
DISCUSSION
Finding reproducible and reliable criteria to identify
carotid plaque at high risk of inducing stroke is key to
improving management of asymptomatic carotid stenosis.
Our study conﬁrms the ability of high-resolution MRI to
Table III. Carotid plaque features with respect to NASCET degree of stenosis
Absent/mild stenosis, <50%
(n ¼ 34)a
Moderate stenosis, 50-70%
(n ¼ 42)a
Severe stenosis, >70%
(n ¼ 7)a P
Intraplaque hemorrhage 6 (18) 6 (14) 24 (31) .084
Fibrous cap rupture 5 (15) 5 (12) 14 (18) .676
Gadolinium enhancement 22 (65) 24 (57) 49 (63) .763
Large lipid core 12 (35) 10 (24) 22 (28) .542
NASCET, North American Symptomatic Carotid Endarterectomy Trial.
aNumber (%).
Fig. Carotid plaque composition with time since stroke. FC,
Fibrous cap; GE, gadolinium enhancement; IP, intraplaque; LC,
lipid-rich necrotic core.
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tomatic from asymptomatic patients. The prevalences of
IPH, FCR, and inﬂammation (GE) identiﬁed on MRI
were signiﬁcantly higher in symptomatic than in asymptom-
atic patients. The prevalences of IPH and FCR were still
signiﬁcantly higher after multivariate analysis. The preva-
lence of IPH was signiﬁcantly higher in symptomatic
patients regardless of the time since stroke, whereas the
prevalence of FCR was signiﬁcantly higher only in acutely
symptomatic patients.
The absence of signiﬁcant differences in demographic
characteristics and inﬂammatory status between asymptom-
atic and symptomatic patients is not surprising and conﬁrms
the need for further investigations to identify patients at
high risk for stroke. We observed that diabetes and coronary
artery disease tend to be more frequent in asymptomatic
than in symptomatic patients certainly because of recruit-
ment bias related to the systematic screening for carotid
stenosis in this population. We also observed a trend toward
higher usCRP levels among symptomatic patients. This
result is consistent with previous studies that reported that
serum usCRP levels are associated with the presence of
neurological symptoms and plaque instability in patients
with carotid artery disease.14,15 Our study may be under-
powered to show statistical signiﬁcance.
Fibrous cap visualization using HR-MRI has already
established good agreement with histological ﬁndings but
only with moderate reproducibility.5,6,16 Several magnetic
resonance sequences and combinations have been re-
ported, and different methods for characterizing theﬁbrous cap have been proposed. To improve the reliability
of ﬁbrous cap characterization, we chose the combination
of TOF- and post-gadolinium T1-weighted sequences
(Supplementary Fig, online only). Consistent with previ-
ously published data we conﬁrmed, in a large cohort of
patients, the higher prevalence of FCR in symptomatic
patients.8-10,17-19 We also showed that this difference exists
for acutely symptomatic patients, but it disappears for
symptomatic patients 15 days after stroke, probably
because of a healing process. These results conﬁrm histo-
logical data and a recent study using HR-MRI and high-
light the accuracy of MRI in detecting different stages of
plaque in symptomatic patients.3,20
The role of IPH in atherosclerotic disease progression
and cerebrovascular events has recently attracted serious
interest.21 MRI-histopathology correlation studies have
shown that IPH can be detected with HR-MRI with good
accuracy and high speciﬁcity and sensitivity.4,22,23 Our
results conﬁrm the relationship between the presence of
IPH and the occurrence of clinical cerebral events and are
consistent with recent studies.17,24,25 Turc et al26 recently
reported an association between IPH and patient symp-
toms, with a higher prevalence of IPH in patients with
more severe clinical presentations. Our ﬁndings showed
a signiﬁcant difference between symptomatic and asymp-
tomatic patients regardless of the time since stroke. This
result is consistent with the Oxford Plaque Study, which
found in more than 526 symptomatic patients with carotid
plaque that the association between IPH and the time since
stroke was weak.3 A recent histological study reports a very
high prevalence (around 70%) of IPH in carotid plaque in
symptomatic as well as asymptomatic patients.27 Further-
more, two different stages of IPH have been identiﬁed:
organized and amorphous.28 At the same time, it has been
reported that MRI can be used to differentiate fresh, recent,
and old hemorrhage from the signal on TOF-, T1-, and T2-
weighted sequences.21 The prevalence of IPH in our series,
as well in other series reportingMRI ﬁndings, is much lower
(around 30%-40%) than that observed during histological
analysis. These discrepancies may be related to small IPH
undetectable because of the low spatial resolution of MRI.
It has previously been shown that HR-MRI can quan-
tify LC in vivo in carotid plaque with a high correlation
with histology and with high speciﬁcity and sensistiv-
ity.29,30 Our results showed a higher prevalence of large
LC in symptomatic patients, but the difference was not
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of power of the study. Cappendijk et al30 also failed to
show a statistical difference between symptomatic and
asymptomatic patients, whereas Ota et al more recently re-
ported that large LC is associated with ﬁbrous cap status
and, therefore, plaque vulnerability.31 Deﬁnition and
measurement of “large” LC are not well established and
can explain this disagreement.
Carotid plaque GE related to the presence of neoves-
sels, inﬁltration of inﬂammatory cells, and matrix degrada-
tion was signiﬁcantly higher in symptomatic patients,
consistent with previous studies.11-13,32 However, the
statistical signiﬁcance was weak and was not any stronger
after multivariate analysis. In the Oxford Plaque Study,
high macrophage density was strongly associated with
FCR and time since stroke, whereas neovascularization
and lymphocyte inﬁltration were not associated with either
FCR or time since stroke. These results may explain the
weak association between patient symptoms and GE.
We focused our image analysis on the most established
features in terms of MRI deﬁnition and histological correla-
tion. Calciﬁcation or ﬁbrous tissue can also be identiﬁed on
MRI, but their quantiﬁcation remains an issue. Moreover, it
is still unclear whether these are features of stable or unstable
plaque. On the basis of our study, we do not know if other
features are correlated or not with patient symptoms.
Other imaging modalities have been proposed for
high-risk stratiﬁcation through carotid plaque characteriza-
tion. Ultrasound plaque classiﬁcation based on echoluency
and the pixel grayscale value has been proposed. Grayscale
median value, plaque area, and juxtaluminal black area have
been shown to be predictive factors in the Asymptomatic
Carotid Stenosis and Risk of Stroke Study.33 Despite these
results and the fact that it is widely available, is easy to use,
is less expensive than other imaging modalities, and may be
repeated as often as necessary, plaque characterization by
carotid ultrasonography remains rarely used. A recent study
comparing carotid MRI, carotid ultrasonography, and
histopathological ﬁndings of plaque specimens removed
during carotid endarterectomy concluded that ﬁndings of
carotid ultrasonography and MRI are closely associated
with carotid endarterectomy specimen morphology, but
ultrasonography alone is insufﬁcient to diagnose plaque
type accurately in some patients.34 Furthermore, although
standard carotid ultrasonography can accurately analyze
plaque surface and detect soft plaque, it does not allow
visualization of intraplaque hemorrhage and inﬂammation,
both major criteria of instability. Multidetector computed
tomography angiography could also characterize some
vulnerable carotid plaque features in a short time and
with high spatial resolution. Even though it is an excellent
modality for assessing plaque ulceration and plaque calciﬁ-
cation, it appears more limited in the evaluation of soft
tissue and requires radiation exposure.
CONCLUSIONS
High-resolution magnetic resonance imaging is able to
identify all histological characteristics of vulnerable plaquewith good reliability and high speciﬁcity and sensitivity.
HR-MRI features of plaque vulnerability are well correlated
with patient symptoms. Large prospective studies are
required to conﬁrm that criteria visualized on HR-MRI
are predictive of neurological events and that HR-MRI
allows better patient selection for interventional therapies.
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1051.e1 Millon et al April 2013APPENDIX (online only). Criteria for identiﬁcation of
features of vulnerable carotid plaque
Lipid core. Isosignal on time of ﬂight (TOF)- and
T1-weighted images and hyposignal to isosignal on proton
density (PD)-weighted images.
Large lipid core. Measurement was performed on the
image showing the thicker lipid-rich necrotic core
(LRNC) by dividing the thickness of the LRNC in the
radial direction by the thickness of the plaque on the slice.
A large LRNC was deﬁned as one occupying more than
50% of vessel wall thickness.
Fibrous cap rupture. Disrupted dark band or no visible
dark band adjacent to the lumen on TOF-weighted angio-
grams and/or presence of ﬁbrous cap discontinuity on
postcontrast T1-weighted images.
Intraplaque hemorrhage. Hyperintense signal on
TOF- and T1-weighted images and/or hyperintense signalSupplementary Table (online only). Patient characteristics a
Period 1b (n ¼ 52) Per
Clinical characteristics: Symptoms 20 (38) 14
Demographics
Age 70 (10, 43-86) 71
Female 17 (33) 13
Active smokers 13 (25) 11
Hypertension 38 (73) 41
Diabetes 13 (25) 18
Dyslipidemia 30 (58) 29
Body mass index 26 (4, 19-34) 26
Coronary artery disease 15 (29) 12
Medications
Statin 40
Aspirin 42
Anticoagulant 7
Biological inﬂammatory markers
Ultrasensitive C-reactive
protein (mg/L) 7.7 (26.5, 0.4-37.5) 10.7
Fibrinogen (g/L) 4.0 (1.0, 2.4-6.8) 3.9
Carotid plaque features
Plaque thickness 4.7 (1.3, 3.0-8.1) 4.5
Degree of stenosis 63.2
Intraplaque hemorrhage 9
Fibrous cap rupture 9
Gadolinium enhancement 31
Large lipid core 18
aContinuous variables were expressed as mean and standard deviation and range
bPeriod 1: January to June 2010; period 2: June 2010 to March 2011; period 3on precontrast mask of gadolinium-enhanced magnetic
resonance angiogram.
Gadolinium enhancement in plaque: Both observers
visually analyzed signal changes in the vessel wall in the
postcontrast images as compared with corresponding pre-
contrast images and contoured the region of interest
(ROI) where they found uptake. Using an in-house soft-
ware for manual image registration, the mean signal inten-
sity (SI) for each ROI was measured and normalized to the
SI in the adjacent sternocleidomastoid muscle. The
percentage of SI change was automatically calculated as
follows: (SI plaque post 3 SI muscle pre)/(SI plaque pre
3 SI muscle post). Precautions were taken to exclude
images with prominent ﬂow artifacts. When pre- and post-
contrast images could not be co-registered, data were
excluded from the analysis.nd plaque features: Evolution during the studya
iod 2b (n ¼ 51) Period 3b (n ¼ 51) P
(27) 18 (35) .478
(10, 35-91) 69 (10, 45-91) .397/.368/.122
(25) 14 (27) .704
(22) 13 (25) .880
(80) 39 (76) .680
(35) 17 (33) .487
(57) 32 (63) .807
(4, 19-36) 27 (4, 22-34) .926/.215/.249
(23) 16 (31) .666
40 42 .783
42 48 .108
5 2
(25.9, 0.2-287) 5.1 (26.3, 0.6-30.5). .696/.237/.174
(1.0, 2.0-9.0) 3.9 (1.0, 2.6-6.5) .474/.523/1
(1.3, 3.0-7.3) 4.9 (1.3, 3.0-8.3) .664/.533/.174
66.9 73.1 .240/.007/.127
11 16 .222
10 5 .360
34 30 .668
15 11 .337
. Categorical variables were expressed as frequence and percentages.
: March to November 2011.
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Volume 57, Number 4 Millon et al 1051.e2Supplementary Fig (online only). Features of vulnerable carotid plaque: Magnetic resonance imaging and histological correlation.
Fibrous cap rupture:Time of ﬂight (TOF)-, proton density (PD)-, and T1-weighted sequences showed a ﬁbrous cap discontinuity conﬁrmed
by a localized ﬁbrous cap rupture on histolgy (hematoxylin and eosin [HE] staining). Intraplaque hemorrhage: Magnetic resonance
angiography (MRA), mask, and PD- and T1-weighted sequences showed intraplaque hypersignal resulting from intraplaque hemorrhage
conﬁrmed by histology (HE staining). Gadolinium enhancement: T1-weighted and post-gadolinium T1-weighted sequences showed focal
enhancement in the shoulder region of the plaque corresponding to an area rich in neovessels (CD34þ) andmacrophages (CD68þ).Lipid core:
PD-, T1-, and post-gadolinium T1-weighted sequences showed intraplaque isosignal (PD- and T1-weighted sequences) and hyposignal (post-
gadolinium T1-weighted sequence) corresponding to a large lipid core on histology (HE stain).
